Regulatory role of nucleophosmin during the differentiation of human liver cancer cells

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 264-272

  Xu, Dong Hui ^a   Liu, Fan ^a   Li, Xiao ^a   Chen, Xiang Feng ^a   Jing, Guang Jun ^a   Wu, Fu Yun ^a   Shi, Song Lin ^a   Li, Qi Fu ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Cell differentiation; Human liver cancer; Nuclear matrix; Nucleophosmin; Protein interaction

Indexed keywords

HEXAMETHYLENEBISACETAMIDE; MESSENGER RNA; MYC PROTEIN; NUCLEOPHOSMIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN C FOS; PROTEIN P53; RETINOBLASTOMA PROTEIN; ACETAMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; NUCLEAR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL LYSATE; CELL NUCLEUS MATRIX; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; LIVER CANCER; LIVER CANCER CELL LINE; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; CELL NUCLEUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACETAMIDES; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NUCLEAR PROTEINS;

EID: 84902598369     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2407     Document Type: Article

References (25)

1. Grisendi S, Mecucci C, Falini B and Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer 6: 493-505, 2006.
2. Lindström MS: Elucidation of motifs in ribosomal protein S9 that mediate its nucleolar localization and binding to NPM1/nucleophosmin. PLoS One 7: e52476, 2012.
3. Lim MJ and Wang XW: Nucleophosmin and human cancer. Cancer Detect Prev 30: 481-490, 2006.
4. Tsui KH, Juang HH, Lee TH, Chang PL, Chen CL and Yung BY: Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Acta Pharmacol Sin 29: 364-370, 2008.
5. Hsu CY and Yung BY: Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int J Cancer 88: 392-400, 2000.
6. Li QF, Shi SL, Liu QR, Tang J, Song J and Liang Y: Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin. Int J Biochem Cell Biol 40: 1918-1929, 2008.
7. Liang Y, Li QF, Zhang XY, Shi SL and Jing GJ: Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. J Cell Biochem 106: 849-857, 2009.
8. Tang J, Niu JW, Xu DH, Li ZX, Li QF and Chen JA: Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation. World J Gastroenterol 13: 2791-2797, 2007.
9. Derenzini M, Sirri V, Trere D and Ochs RL: The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 73: 497-502, 1995.
10. Michishita E, Kurahashi T, Suzuki T, et al: Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells. Exp Gerontol 37: 885-890, 2002.
11. Hsu CY and Yung BY: Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Oncogene 16: 915-923, 1998.
12. Dergunova NN, Bulycheva TI, Artemenko EG, et al: A major nucleolar protein B23 as a marker of proliferation activity of human peripheral lymphocytes. Immunol Lett 83: 67-72, 2002.
13. Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK and Partin AW: Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 39: 298-304, 1999.
14. Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN and Bosman FT: Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178: 48-52, 1996.
15. Zhang Y: The ARF-B23 connection: implications for growth control and cancer treatment. Cell Cycle 3: 259-262, 2004.
16. Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L and Rosen A: Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci USA 100: 12361-12366, 2003.
17. You BJ, Huang IJ, Liu WH, Hung YB, Chang JH and Yung BY: Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells. Naunyn Schmiedebergs Arch Pharmacol 360: 683-690, 1999.
18. Gjerset RA: DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol 37: 239-251, 2006.
19. Li Z, Boone D and Hann SR: Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci USA 105: 18794-18799, 2008.
20. Yung BY: c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells. FEBS Lett 578: 211-216, 2004.
21. Arabi A, Rustum C, Hallberg E and Wright AP: Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 116: 1707-1717, 2003.
22. Grandori C, Gomez-Roman N, Felton-Edkins ZA, et al: c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 311-318, 2005.
23. Maiguel DA, Jones L, Chakravarty D, Yang C and Carrier F: Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol 24: 3703-3711, 2004.
24. Colombo E, Marine JC, Danovi D, Falini B and Pelicci PG: Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4: 529-533, 2002.
25. Lin CY, Liang YC and Yung BY: Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell Signal 18: 2041-2048, 2006.